Objective : We examined the usefulness of HNF4α immunocytochemistry for differentiating cancer cells from normal or benign cells in body cavity fluids, and investigated the possibility of diagnosis of primary lesions.
Study Design : We studied the HNF4α expression in 120 cavity fluid preparations from patients with gastric cancer (24), pancreatic cancer (18), colorectal cancer (7), bile duct cancer (5), ovarian cancer (35), lung cancer (14), renal cell carcinoma (2), malignant mesothelioma (6), and malignant lymphoma (2).
Results : The cancer cells in all cases, from adenocarcinoma of the digestive organs to renal cell carcinomas, were positive for HNF4α. In 4/35 cases of ovarian cancer and 1/7 cases of endometrial carcinoma in which the test result was positive, the histological type of cancer was mucinous adenocarcinoma. On the other hand, mesothelial cells, macrophages and other inflammatory cells were negative for HNF4α.
Conclusions : We concluded that HNF4α is a very useful marker for discrimination between cancer cells and benign cells in ascitic fluid. In pleural fluid also, it is useful for differentiating between metastatic and primary lung adenocarcinoma. Thus, immunocytochemical staining for HNF4α is useful for the diagnosis of cancer, especially when used together with staining for other known antibodies.
View full abstract